melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
About Us
Our Services
HIGH THROUGHPUT IN VIVO PHARMACOLOGY:
DISCOVERY SERVICES:
Our Technology
Partnering with Us
Press & Publications
Contact Us
melior melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling

Our Technology assay applications


Melior's theraTRACE® discovery platform includes over 35 standardized and
validated models relevant to the following indications/therapeutic areas:

  • Neurodegenerative Diseases
    • Epilepsy
    • Multiple Sclerosis
    • Alzheimer's disease*
    • Parkinson's disease
  • Psychiatry
    • Anxiety
    • Addiction
    • Depression
  • General Neurology
    • Irwin Evaluations
    • Locomotor Activity
    • Circadian Rhythm
    • Thermoregulation
  • Pain
    • Mechanical
    • Thermal
    • Chemical
    • Visceral
  • Inflammation
    • Arthritis
    • Asthma
    • Sepsis
  • Neuroinflammation
    • Multiple Sclerosis
  • Cardiovascular
    • Hypertension
    • Thrombosis
    • Small Animal Telemetry
  • Metabolic Disease
    • Diabetes (type II)
    • Metabolic Syndrome
    • Obesity
  • Gastrointestinal
    • Irritable Bowel Syndrome
    • Morphine-induced constipation
  • Immunology
    • Allergic reaction
    • Monocyte infiltration
  • Urology
    • Overactive Bladder

* Amyloid Plaque Deposition - Exclusive Model


 
home